ULTRAPRO MESH UNKNOWN PRODUCT
Report
- Report Number
- 2210968-2018-72664
- Event Type
- Injury
- Date Received
- May 8, 2018
- Report Date
- April 10, 2018
- Manufacturer
- ETHICON INC.
- Product Code
- FTL
- PMA / PMN Number
- K033337
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- OTHER
Narratives
(B)(4). THIS REPORT IS RELATED TO A JOURNAL ARTICLE, THEREFORE NO PRODUCT WILL BE RETURNED FOR ANALYSIS AND THE BATCH HISTORY RECORDS CANNOT BE REVIEWED AS THE LOT NUMBER HAS NOT BEEN PROVIDED. NO SPECIFIC PATIENT INFORMATION REGARDING EVENTS HAS BEEN PROVIDED. IF FURTHER DETAILS ARE RECEIVED AT THE LATER DATE A SUPPLEMENTAL MEDWATCH WILL BE SENT. (B)(4).
TITLE: LONG-TERM ASSESSMENT OF SURGICAL AND QUALITY OF LIFE OUTCOMES BETWEEN LIGHTWEIGHT (ULTRAPRO) AND HEAVYWEIGHT (STANDARD 3DMAXTM) MESH IN LAPAROSCOPIC INGUINAL HERNIA REPAIR THE AIM OF THIS STUDY WAS TO COMPARE SURGICAL AND QUALITY OF LIFE (QOL) OUTCOMES BETWEEN LIGHTWEIGHT MESH (LWM; ULTRAPRO MESH) AND HEAVYWEIGHT MESH (HWM; STANDARD 3DMAXTM) UTILIZED IN LAPAROSCOPIC INGUINAL HERNIA REPAIR (LIHR). A PROSPECTIVE, SINGLE-CENTER, HERNIA-SPECIFIC DATABASE/STUDY WAS PERFORMED FOR ALL ADULT LIHR FROM 1999 TO MAY 2015. A TOTAL OF 692 PATIENTS WERE REPAIRED WITH LWM (ULTRAPRO MESH) AND 391 PATIENTS WITH HWM (STANDARD 3DMAXTM). THE LWM PATIENTS WERE YOUNGER (51.9I14.7 VERSUS 54.1+/-14.5YEARS; P<0.001). IN THE LWM GROUP, REPORTED COMPLICATIONS INCLUDED POST-OPERATIVE SEROMA (30.1%), SYMPTOMATIC DISCOMFORT (57.1%) 2 WEEKS POST-SURGERY, AND MORE MESH SENSATION (12.4%) 24 MONTHS POST-SURGERY. IT WAS CONCLUDED THAT THOSE WHO HAD LWM WERE YOUNGER AND LESS CO-MORBID, BUT HAD MORE POST-OPERATIVE SEROMA FORMATION. LWM WAS ASSOCIATED WITH GREATER DISCOMFORT AT 2 WEEKS AND MORE MESH SENSATION AT 24 MONTHS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 336140 | ULTRAPRO MESH UNKNOWN PRODUCT | MESH, SURGICAL, POLYMERIC | FTL | ETHICON INC. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |